GlassScriptPhysician profile
Janice Beaman
NPI 1356344311
$1,688.34
in general payments reported to CMS, 2019-2025
16 companies · $191 in 2025
The $191 reported for 2025 was more than what a typical Women'S Health (Nurse Practitioner) provider received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $208 · 2022: $406 · 2023: $521 · 2024: $362 · 2025: $191.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $398.14 | 2023-2025 | Veozah |
| Abbvie INC. | $295.83 | 2021-2023 | |
| Mayne Pharma Commercial LLC | $200.18 | 2022-2023 | |
| Pfizer INC. | $167.77 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $143.27 | 2023-2025 | Myfembree, Gemtesa |
| Therapeuticsmd, INC. | $105.36 | 2021-2022 | |
| Exact Sciences Corporation | $101.99 | 2023-2025 | Cologuard Collection Kit |
| Mycovia Pharmaceuticals, INC. | $53.17 | 2023 | Vivjoa |
| Agile Therapeutics, INC. | $41.54 | 2023-2024 | Twirla |
| Biogen, INC. | $33.96 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $30.91 | 2022 | |
| Exeltis, USA INC. | $30.64 | 2022 | |
| Avion Pharmaceuticals | $27.47 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.48 | 2021 | |
| Axonics, INC. | $22.13 | 2023 | Axonics, Bulkamid |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $13.50 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice Beaman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.